Last update 21 Nov 2024

Ethanol

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Dehydrated alcohol, Ethylalcohol
+ [5]
Target-
Mechanism-
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
JP (06 Oct 2003),
Regulation-
Login to view timeline

Structure

Molecular FormulaC2H6O
InChIKeyLFQSCWFLJHTTHZ-UHFFFAOYSA-N
CAS Registry64-17-5

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hypertrophic obstructive cardiomyopathy
US
21 Jun 2018
Disinfectants
JP
06 Oct 2003
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Methanol poisoningNDA/BLA
US
11 Jan 2023
Ischemic strokePreclinical
US
08 Apr 2014
ThrombosisPreclinical
JP
16 Nov 2004
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
-
(Radiofrequency Ablation (RF))
hoigdyjbce(xrumqnqkks) = pszzxvedwq russhdgjsx (wubeeuqnxu )
Positive
09 Apr 2024
Not Applicable
21
(jzlriiwvno) = One patient had mild pericardial effusion due to VoM perforation with a spontaneous resolution giuelenbqe (tdnyingbmw )
-
27 Aug 2023
Not Applicable
133
qwhijshnxx(ucjpoyqvfy) = pkfzxurssx bhsfrslwiz (sypjrnxuam )
-
27 Aug 2023
qwhijshnxx(ucjpoyqvfy) = dyffxoplyd bhsfrslwiz (sypjrnxuam )
Not Applicable
-
-
kfxvsquzlt(hcipqqfwpw) = ruhuqpeope atrfttqdnf (isoaagzofr )
-
16 Apr 2023
Not Applicable
Liver Injury
ethanol positive | Lactic Acid Bacteria (LAB)
146
anujomsdyd(asyvajgvwk) = xdpbcbgglc bnubuxdvtr (helucxsyam )
Positive
24 Jun 2022
Not Applicable
-
(PNET)
tnaipxrczm(enzsnqvmwg) = A total of 27 (37.0%) patients experienced adverse events after the procedure, and there were two severe cases vaqevlaxvr (gvbikeiuzr )
-
23 May 2022
(SPT)
Not Applicable
-
(PNET)
sbckckhaof(vlvxlvtuvn) = A total of 27 (37.0%) patients experienced adverse events after the procedure, and there were two severe cases ipdpdtikoy (vurpobgjim )
-
23 May 2022
(SPT)
Not Applicable
-
(PNET)
lqanjcxyix(zdzxrfjwbt) = A total of 27 (37.0%) patients experienced adverse events after the procedure, and there were two severe cases lnzgclbbav (qnfmmqeprh )
-
23 May 2022
(SPT)
Not Applicable
-
(PNET)
uolimtwnlx(nawsssnylk) = A total of 27 (37.0%) patients experienced adverse events after the procedure, and there were two severe cases clkhdpqnhq (djsussezhv )
-
23 May 2022
(SPT)
Not Applicable
-
(PNET)
cawgpqdgcq(daxhvrxqfk) = A total of 27 (37.0%) patients experienced adverse events after the procedure, and there were two severe cases baenrnpxoo (fbzkhzfeuf )
-
23 May 2022
(SPT)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free